1590-1591 / 1778
G≥1: 89%
G≥2: 29%
G≥3: 4%
Vaginal morbidity overview
•
N=588 LACC within EMBRACE study
•
Prospective assessment of morbidity
(CTCAE 3) at baseline and regular
follow-ups (median 15 months)
•
Endpoints: vaginal stenosis, dryness,
mucositis, bleeding, fistula
Kirchheiner et al.
IJROBP 2014